scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1053721406 |
P356 | DOI | 10.1007/BF00179927 |
P698 | PubMed publication ID | 3122248 |
P2093 | author name string | T Glaser | |
J Traber | |||
D G Spencer | |||
P2860 | cites work | Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT | Q48738976 |
Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT). | Q52261135 | ||
Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites. | Q52275732 | ||
DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines. | Q52282914 | ||
Behavioral effects of 5-methoxy-N,N-dimethyltryptamine and dose-dependent antagonism by BC-105. | Q52284566 | ||
Effects of 8-OH-DPAT, lisuride and some ergot-related compounds on the acoustic startle response in the rat | Q67301107 | ||
Pharmacological analysis of the behavioural and thermoregulatory effects of the putative 5-HT1 receptor agonist, RU 24969, in the rat | Q70151999 | ||
Effects of a new type of 5-HT receptor agonist on male rat sexual behavior | Q70561140 | ||
Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists | Q71036856 | ||
Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat | Q71262469 | ||
Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain | Q71482384 | ||
Hallucinogenic agents as discriminative stimuli: a correlation with serotonin receptor affinities | Q71522257 | ||
Buspirone: Action on serotonin receptors in calf hippocampus | Q72553007 | ||
Differential effects of a new serotoninomimetic drug, 8-OH-DPAT, on copulatory behavior and pelvic thrusting pattern in the male rat | Q72813683 | ||
Development of selective tolerance to the serotonin behavioral syndrome and suppression of locomotor activity after repeated administration of either 5-MeODMT or mCPP | Q93580151 | ||
Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist | Q28282022 | ||
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents | Q34262666 | ||
Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors | Q34562816 | ||
Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes | Q34683834 | ||
The stereoselectivity of serotonin uptake in brain tissue and blood platelets: the topography of the serotonin uptake area | Q39478261 | ||
The mechanism of action of fenfluramine | Q40489566 | ||
Hallucinogens as a discriminative stimuli: Generalization of DOM to a 5-methoxy-N, N-dimethyltryptamine stimulus | Q40596498 | ||
Subtypes of the 5-HT receptor mediating the behavioural responses to 5-methoxy-N,N-dimethyltryptamine in the rat. | Q41352922 | ||
8-Hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicits eating in free-feeding rats by acting on central serotonin neurons | Q41353222 | ||
A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors | Q41740406 | ||
The 5-HT1 receptor agonist RU-24969 decreases 5-hydroxytryptamine (5-HT) release and metabolism in the rat frontal cortex in vitro and in vivo | Q41786566 | ||
Possible 5-hydroxytryptamine1 (5-HT1) receptor involvement in the stimulus properties of 1-(m-trifluoromethylphenyl)piperazine (TFMPP). | Q42018192 | ||
Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin | Q42203475 | ||
TFMPP may produce its stimulus effects via a 5-HT1B mechanism | Q42226581 | ||
Autoradiographic identification and topographical analyses of high affinity serotonin receptor subtypes as a target for the novel putative anxiolytic TVX Q 7821. | Q43755977 | ||
On the in vivo and in vitro actions of fenfluramine and its derivatives on central monoamine neurons, especially 5-hydroxytryptamine neurons, and their relation to the anorectic activity of fenfluramine | Q44263723 | ||
Binding of the putative anxiolytic TVX Q 7821 to hippocampal 5-hydroxytryptamine (5-HT) recognition sites | Q44979498 | ||
Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome | Q45027380 | ||
Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex | Q45333608 | ||
Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain | Q46832632 | ||
Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists | Q46930255 | ||
[3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. | Q46980089 | ||
The interoceptive discriminative stimuli induced by the novel putative anxiolytic TVX Q 7821: behavioral evidence for the specific involvement of serotonin 5-HT1A receptors | Q48258329 | ||
Buspirone decreases the activity of serotonin-containing neurons in the dorsal raphe in freely-moving cats | Q48284697 | ||
Ipsapirone depresses neuronal activity in the dorsal raphe nucleus and the hippocampal formation | Q48288246 | ||
Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors | Q48289171 | ||
Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug | Q48299256 | ||
[125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes. Comparison with [3H]mesulergine and [3H]5-HT binding | Q48299880 | ||
(-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists | Q48300462 | ||
5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus | Q48318391 | ||
Pharmacological characterization of release-regulating serotonin autoreceptors in rat cerebellum | Q48319635 | ||
Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites | Q48332579 | ||
Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum | Q48352105 | ||
In vivo voltammetry in the suprachiasmatic nucleus of the rat: effects of RU24969, methiothepin and ketanserin | Q48377699 | ||
The effects of a 5-HT1 receptor ligand isapirone (TVX Q 7821) on 5-HT synthesis and the behavioural effects of 5-HT agonists in mice and rats | Q48419501 | ||
Stereoselective blockade at the 5-HT autoreceptor and inhibition of radioligand binding to central 5-HT recognition sites by the optical isomers of methiothepin | Q48419735 | ||
Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites | Q48419772 | ||
1-(2-Pyrimidinyl)-piperazine as active metabolite of buspirone in man and rat. | Q48421321 | ||
[3H]DOB: a specific agonist radioligand for 5-HT2 serotonin receptors | Q48444198 | ||
Selective labeling of 5-HT1A and 5-HT1B binding sites in bovine brain | Q48451948 | ||
Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype | Q48468938 | ||
The putative 5-HT1 receptor agonist, RU 24969, inhibits the efflux of 5-hydroxytryptamine from rat frontal cortex slices by stimulation of the 5-HT autoreceptor | Q48485986 | ||
5-HT-1a and 5-HT-1b selectivity of two phenylpiperazine derivatives: evidence for 5-HT-1b heterogeneity | Q48499755 | ||
A functional correlate for the dihydropyridine binding site in rat brain | Q48509384 | ||
3H-TVX Q 7821: identification of 5-HT1 binding sites as target for a novel putative anxiolytic | Q48532640 | ||
Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. | Q48574385 | ||
Determination of selective and nonselective compounds for the 5-HT 1A and 5-HT 1B receptor subtypes in rat frontal cortex | Q48594638 | ||
Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821. | Q48662052 | ||
The behavioural effects of RU 24969, a suggested 5-HT1 receptor agonist in rodents and the effect on the behaviour of treatment with antidepressants | Q48663812 | ||
Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain | Q48670125 | ||
P433 | issue | 2 | |
P921 | main subject | serotonin | Q167934 |
P304 | page(s) | 158-166 | |
P577 | publication date | 1987-01-01 | |
P1433 | published in | Psychopharmacology | Q1422802 |
P1476 | title | Serotonin receptor subtype mediation of the interoceptive discriminative stimuli induced by 5-methoxy-N,N-dimethyltryptamine | |
P478 | volume | 93 |
Q52185700 | A comparison of N,N-dimethyltryptamine, harmaline, and selected congeners in rats trained with LSD as a discriminative stimulus. |
Q30358201 | Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine. |
Q67900241 | Buspirone affects hippocampal rhythmical slow activity through serotonin1A rather than dopamine D2 receptors |
Q37302207 | Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice |
Q24594834 | Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice |
Q34435958 | Drug discrimination studies with ibogaine |
Q45279141 | Effect of Hallucinogens on Unconditioned Behavior |
Q33887065 | Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics |
Q52176483 | Further investigations of the serotonergic properties of the ibogaine-induced discriminative stimulus. |
Q37315499 | Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines |
Q36844764 | Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms |
Q24620764 | Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens |
Q48963025 | Pharmacodynamic effects of serotonin (5-HT) receptor ligands in pigs: stimulation of 5-HT2 receptors induces malignant hyperthermia |
Q36023615 | Psilocybin-induced stimulus control in the rat. |
Q24633393 | Psychedelic 5-Methoxy-N,N-Dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions |
Q34828820 | S(-)Propranolol as a discriminative stimulus and its comparison to the stimulus effects of cocaine in rats |
Q33748918 | Serotonergic receptor subtypes and hallucinogen-induced stimulus control |
Q37914869 | Serotonin receptors: clinical implications |
Q35085860 | Stimulus control by 5-methoxy-N,N-dimethyltryptamine in wild-type and CYP2D6-humanized mice |
Q59341209 | The Varieties of the Psychedelic Experience: A Preliminary Study of the Association Between the Reported Subjective Effects and the Binding Affinity Profiles of Substituted Phenethylamines and Tryptamines |
Q78035734 | The acute effects of monoamine reuptake inhibitors on the stimulus effects of hallucinogens |
Q24645656 | The behavioral pharmacology of hallucinogens |
Q57178557 | The epidemiology of 5-methoxy- N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption |
Q73363254 | The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors |
Q34570539 | The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats |
Q34312785 | The stimulus properties of LSD in C57BL/6 mice |
Q69202724 | Trends in drug discrimination research analysed with a cross-indexed bibliography, 1984-1987 |
Search more.